Sonic Healthcare to boom with $750m US acquisition

Sonic Healthcare to boom with $750m US acquisition

Sonic Healthcare (ASX: SHL) could become one of the world's largest pathology groups after reaching a binding agreement to purchase US company Aurora Diagnostics for US$540 million ($750 million).

If the deal passes the necessary anti-trust approvals, Florida-based Aurora will bring 1,200 staff including 200 pathologists under the Sonic umbrella with 32 anatomical practices in 19 US states.

In the year to 30 September, Aurora notched pro forma revenue of US$310 million ($431 million) and EBITDA of US$59 million ($82 million).

Sonic has also announced a fully underwritten institutional placement to raise $600 million, as well as a non-underwritten share purchase plan to raise up to $100 million from retail investors in Australia and New Zealand.

"The Aurora acquisition is an exciting and seminal step for Sonic Healthcare and we warmly welcome the management, pathologists and staff working in Aurora's outstanding anatomical pathology practices around the US," says Sonic's CEO Dr Colin Goldschmidt.

"The integration of these practices into Sonic's existing US operations, in conjunction with Aurora's management team, will offer Sonic Healthcare USA the scale and critical mass to boost the national promotion of Sonic's unique Medical Leadership model in the US laboratory and pathology markets."

The integration of Aurora will be led by its US CEO Dr. Jerry Hussong, with support from Goldschmidt, Sonic's global chief medical officer Dr Stephen Fairy and Aurora's management team.

Never miss a news update, subscribe here. Follow us on Facebook, LinkedIn, Instagram and Twitter.

Business News Australia

Get our daily business news

Sign up to our free email news updates.

 
Unpacking equity: Finding your funding fit
Partner Content
Armed with a growing business and a great opportunity, a business owner’s next challe...
Australian Business Growth Fund
Advertisement

Related Stories

Marmalade raises $16m as invoice payment startup aims to process $1b in 2024

Marmalade raises $16m as invoice payment startup aims to process $1b in 2024

Melbourne-based invoice payment platform Marmalade has raised $16 m...

Boral rejects Seven Group bid after independent expert says it falls $1 billion short

Boral rejects Seven Group bid after independent expert says it falls $1 billion short

Buildings materials giant Boral (ASX: BLD) has formally rejected a ...

Study links microplastics with human health problems – but there’s still a lot we don’t know

Study links microplastics with human health problems – but there’s still a lot we don’t know

A recent study published in the prestigious New England Journal of ...

Precision fermentation scale-up Cauldron now at "industrially relevant scale" amid $9.5m raise

Precision fermentation scale-up Cauldron now at "industrially relevant scale" amid $9.5m raise

A game-changing technology from Orange, NSW that promises to lift f...